Blue Jet Healthcare Limited (BOM:544009)
India · Delayed Price · Currency is INR 596.10
+1.15 (0.19%)
At close: Aug 21, 2026
Blue Jet Healthcare Revenue
Blue Jet Healthcare had revenue of 2.93B INR in the quarter ending June 30, 2026, a decrease of -17.38%. This brings the company's revenue in the last twelve months to 8.86B, down -27.51% year-over-year. In the fiscal year ending March 31, 2026, Blue Jet Healthcare had annual revenue of 9.47B, down -8.03%.
Revenue (ttm)
8.86B
Revenue Growth
-27.51%
P/S Ratio
12.74
Revenue / Employee
45.19M
Employees
196
Market Cap
112.84B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 9.47B | -826.64M | -8.03% |
| Mar 31, 2025 | 10.30B | 3.18B | 44.74% |
| Mar 31, 2024 | 7.12B | -93.84M | -1.30% |
| Mar 31, 2023 | 7.21B | 375.13M | 5.49% |
| Mar 31, 2022 | 6.83B | 1.85B | 36.99% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Jubilant Pharmova | 86.08B |
| Granules India | 56.32B |
| Viyash Scientific | 35.75B |
| AstraZeneca Pharma India | 24.32B |
| Caplin Point Laboratories | 22.87B |
| FDC Limited | 21.90B |
| Morepen Laboratories | 19.51B |
| Sanofi India | 18.05B |